Breaking News Instant updates and real-time market news.

KITE

Kite Pharma

$72.49

1.9 (2.69%)

06:57
05/19/17
05/19
06:57
05/19/17
06:57

Jefferies survey 'extremely bullish' for Kite's Axi-cel

Jefferies analyst Biren Amin says his firm's first proprietary survey on the non-Hodgkin lymphoma landscape proved "extremely bullish" for Kite Pharma's Axi-cel in 2018 and 2019. Respondents expect 30% and 40% of second-line patients to be treated with Axi-cel in the two years, Amin tells investors in a research note. The analyst believes the survey supports his above-consensus estimates. He keeps a Buy rating on Kite Pharma with a $101 price target.

  • 02

    Jun

  • 06

    Jun

  • 20

    Jun

KITE Kite Pharma
$72.49

1.9 (2.69%)

05/09/17
WEDB
05/09/17
DOWNGRADE
WEDB
Underperform
Kite Pharma downgraded to Underperform from Neutral at Wedbush
Wedbush analysts David M. Nierengarten,and Robert Driscoll downgraded Kite after a patient taking its axi-cel drug reportedly died of cerebral edema. The analysts still expect the drug to be approved, but they think it's less likely to be approved in additional indications amid increased safety concerns. The analysts now expect the product launch to be "complex," leading to lower than expected revenue for Kite. Target to $54 from $60.
05/09/17
ADAM
05/09/17
NO CHANGE
Target $90
ADAM
Buy
Kite Pharma should be bought aggressively on weakness, says Canaccord
Canaccord analyst John Newman noted the patient who died in the trial being conducted by Kite Pharma was a person who had extremely poor health at baseline and he believes the risk is manageable going forward. He said all protocols will be modified going forward to inform doctors and patients of any risks and will exclude any high risk patients from treatment. Newman reiterated his Buy rating and $90 price target on Kite Pharma shares.
05/08/17
RAJA
05/08/17
DOWNGRADE
RAJA
Market Perform
Raymond James downgrades Kite Pharma on valuation amid 12% selloff
Raymond James analyst Reni Benjamin downgraded Kite Pharma to Market Perform from Outperform after the company reported Q1 results and disclosed one cerebral edema related death in a KTE-C19 expansion study. The analyst is not overly concerned by the death, but believes the expectations for KTE-C19's commercial prospects are largely priced in at current share levels. The stock may recover from today's "overreaction," however, Benjamin tells investors in a post-earnings research note. Kite in afternoon trading is down 12%, or $10.12, to $71.66.
05/08/17
RAJA
05/08/17
DOWNGRADE
RAJA
Market Perform
Kite Pharma downgraded to Market Perform from Outperform at Raymond James

TODAY'S FREE FLY STORIES

BCS

Barclays

$10.66

-0.12 (-1.11%)

07:36
05/31/17
05/31
07:36
05/31/17
07:36
Periodicals
Barclays plans sale of $2B stake in African division, Sky News says »

Barclays is making plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CADE

Cadence Bancorporation

$22.32

0.03 (0.13%)

07:36
05/31/17
05/31
07:36
05/31/17
07:36
Initiation
Cadence Bancorporation initiated  »

Cadence Bancorporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CXRX

Concordia

$1.27

-0.025 (-1.94%)

07:36
05/31/17
05/31
07:36
05/31/17
07:36
Hot Stocks
Concordia: U.K. CMA intends to continue with pricing investigation »

Concordia International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOLD

Amicus

$7.66

-0.27 (-3.40%)

07:36
05/31/17
05/31
07:36
05/31/17
07:36
Hot Stocks
Amicus' SD-101 granted Rare Pediatric Disease designation »

Amicus has received Rare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

AAPL

Apple

$153.67

0.06 (0.04%)

, NVDA

Nvidia

$144.87

3.03 (2.14%)

07:35
05/31/17
05/31
07:35
05/31/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$153.67

0.06 (0.04%)

NVDA

Nvidia

$144.87

3.03 (2.14%)

BABA

Alibaba

$123.91

-0.08 (-0.06%)

MU

Micron

$30.70

0.94 (3.16%)

M

Macy's

$23.60

0.16 (0.68%)

CSX

CSX

$54.22

0.26 (0.48%)

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 09

    Jun

  • 15

    Jun

  • 29

    Jun

07:35
05/31/17
05/31
07:35
05/31/17
07:35
General news
FX Update: The dollar came under pressure »

FX Update: The dollar…

CUI

CUI Global

$3.54

-0.11 (-3.01%)

07:35
05/31/17
05/31
07:35
05/31/17
07:35
Initiation
CUI Global initiated  »

CUI Global initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 15

    Jun

HLIT

Harmonic

$5.10

-0.15 (-2.86%)

07:34
05/31/17
05/31
07:34
05/31/17
07:34
Conference/Events
Harmonic management to meet with Drexel Hamilton »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

ALNY

Alnylam

$64.09

-1.71 (-2.60%)

07:34
05/31/17
05/31
07:34
05/31/17
07:34
Hot Stocks
FDA grants Breakthrough Therapy Designation for Alnylam's Givosiran »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

DAKT

Daktronics

$9.28

0.14 (1.53%)

07:33
05/31/17
05/31
07:33
05/31/17
07:33
Earnings
Daktronics reports Q4 EPS 2c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

EC

Ecopetrol

$9.36

-0.23 (-2.40%)

07:33
05/31/17
05/31
07:33
05/31/17
07:33
Downgrade
Ecopetrol rating change  »

Ecopetrol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNKN

Dunkin' Brands

$58.32

0.15 (0.26%)

07:32
05/31/17
05/31
07:32
05/31/17
07:32
Hot Stocks
Dunkin' Brands names Kate Jaspon as CFO, effective June 5 »

Dunkin' Brands Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

, UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Recommendations
Exact Sciences, UnitedHealth analyst commentary  »

Exact Sciences remains a…

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 06

    Jun

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

, NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 09

    Jun

FRO

Frontline

$5.41

-0.22 (-3.91%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Upgrade
Frontline rating change  »

Frontline upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGHT

8x8, Inc.

$13.60

0.1 (0.74%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Conference/Events
8x8, Inc. management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 06

    Jun

  • 08

    Jun

  • 13

    Jun

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

, FRO

Frontline

$5.41

-0.22 (-3.91%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Recommendations
Gener8 Maritime, Frontline, DHT Holdings analyst commentary  »

Gener8 Maritime advance…

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

FRO

Frontline

$5.41

-0.22 (-3.91%)

DHT

DHT Holdings

$4.20

-0.07 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

, ORCL

Oracle

$45.42

0.16 (0.35%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

ORCL

Oracle

$45.42

0.16 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:25
05/31/17
05/31
07:25
05/31/17
07:25
Technical Analysis
Technical View: Michael Kors drops to new 52-week low after earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CBS

CBS

$61.52

-0.05 (-0.08%)

, CBS.A

$63.50

-0.15 (-0.24%)

07:24
05/31/17
05/31
07:24
05/31/17
07:24
Periodicals
Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says »

CBS (CBS, CBS.A) news…

CBS

CBS

$61.52

-0.05 (-0.08%)

CBS.A

$63.50

-0.15 (-0.24%)

CMCSA

Comcast

$41.10

0.19 (0.46%)

CMCSK

Comcast

DIS

Disney

$108.34

-0.07 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 08

    Jun

  • 15

    Jun

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors drops 7% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

UAA

Under Armour

$19.56

-0.13 (-0.66%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Recommendations
Under Armour analyst commentary  »

Under Armour has reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

07:22
05/31/17
05/31
07:22
05/31/17
07:22
General news
Futures higher ahead of final trading for May »

Stock futures are above…

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:22
05/31/17
05/31
07:22
05/31/17
07:22
Hot Stocks
Michael Kors says to close 100-125 full-price retail stores over next two years »

Michael Kors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MYL

Mylan

$39.36

-0.36 (-0.91%)

07:19
05/31/17
05/31
07:19
05/31/17
07:19
Recommendations
Mylan analyst commentary  »

Pension fund campaign a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.